Cohance Lifesciences News

6 Sept 202612:19 am

Biotechnology6 Sept 2026 · 12:19 am12:19 am

Cohance Lifesciences Invests $18 Million in NJ Bio, Aruka Bio to Sharpen ADC Focus

Cohance Lifesciences is investing $18 million in NJ Bio and Aruka Bio to enhance its focus on Antibody-Drug Conjugates (ADC), aiming for deeper integration of N

4 Sept 20264:20 am

business4 Sept 2026 · 4:20 am4:20 am

Create visual

Cohance Lifesciences to Invest $18 Million in NJ Bio and Aruka Bio

Cohance Lifesciences will invest $18 million to enhance its antibody-drug conjugate strategy, including $13 million in NJ Bio to increase its ownership to 67.3%

6 Aug 20268:16 am

corporate earnings6 Aug 2026 · 8:16 am8:16 am

Create visual

Cohance Lifesciences reports ₹45.19 crore loss in Q1 due to lower revenue

Cohance Lifesciences reported a loss of ₹45.19 crore in the first quarter, attributed to lower revenue.

Cohance Lifesciences News